These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14625668)

  • 1. Fracture risk is decreased in acromegaly--a potential beneficial effect of growth hormone.
    Vestergaard P; Mosekilde L
    Osteoporos Int; 2004 Feb; 15(2):155-9. PubMed ID: 14625668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis.
    Mazziotti G; Biagioli E; Maffezzoni F; Spinello M; Serra V; Maroldi R; Floriani I; Giustina A
    J Clin Endocrinol Metab; 2015 Feb; 100(2):384-94. PubMed ID: 25365312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ; Fig LM; Barkan AL; Shapiro B
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
    Leslie WD; Lix LM;
    J Bone Miner Res; 2011 Mar; 26(3):460-7. PubMed ID: 20839285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vertebral fractures in patients with acromegaly: a 3-year prospective study.
    Mazziotti G; Bianchi A; Porcelli T; Mormando M; Maffezzoni F; Cristiano A; Giampietro A; De Marinis L; Giustina A
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3402-10. PubMed ID: 23771918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients.
    Vestergaard P; Mosekilde L
    World J Surg; 2003 Mar; 27(3):343-9. PubMed ID: 12607064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone material strength index as measured by impact microindentation is altered in patients with acromegaly.
    Malgo F; Hamdy NAT; Rabelink TJ; Kroon HM; Claessen KMJA; Pereira AM; Biermasz NR; Appelman-Dijkstra NM
    Eur J Endocrinol; 2017 Mar; 176(3):339-347. PubMed ID: 28077497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone density of the lumbar spine and femur in acromegaly].
    Hübsch P; Kotzmann H; Svoboda T; Kainberger FM; Bankier A; Seidl G
    Radiologe; 1993 Aug; 33(8):457-61. PubMed ID: 8372172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral neck bone loss predicts fracture risk independent of baseline BMD.
    Nguyen TV; Center JR; Eisman JA
    J Bone Miner Res; 2005 Jul; 20(7):1195-201. PubMed ID: 15940372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone quality in patients with acromegaly].
    Kužma M; Ságová I; Pavai D; Jackuliak P; Killinger Z; Vaňuga P; Payer J
    Vnitr Lek; 2017; 63(9):589-592. PubMed ID: 29120655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB; Erbaş T
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
    Kotzmann H; Bernecker P; Hübsch P; Pietschmann P; Woloszczuk W; Svoboda T; Geyer G; Luger A
    J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Qin G; Christiansen C
    Osteoporos Int; 2006; 17(3):471-7. PubMed ID: 16261280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women.
    Morin SN; Lix LM; Leslie WD
    J Bone Miner Res; 2014 Jul; 29(7):1675-80. PubMed ID: 24535832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T; Fougner SL; Godang K; Schreiner T; Bollerslev J
    Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of multiple sites for the diagnosis of osteoporosis.
    Kanis JA; Johnell O; Oden A; Johansson H; Eisman JA; Fujiwara S; Kroger H; Honkanen R; Melton LJ; O'Neill T; Reeve J; Silman A; Tenenhouse A
    Osteoporos Int; 2006; 17(4):527-34. PubMed ID: 16402164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women.
    Nguyen TV; Center JR; Pocock NA; Eisman JA
    Osteoporos Int; 2004 Jan; 15(1):49-55. PubMed ID: 14593453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.